Ido Goldenberg

Nov 12, 2024 | onlinelibrary.wiley.com | Ido Goldenberg |Rochester Minnesota USA |Arwa Younis |David T. Huang

DATA AVAILABILITY STATEMENT The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Feb 21, 2024 | onlinelibrary.wiley.com | Ido Goldenberg |Arwa Younis |Scott McNitt |Helmut Klein

DATA AVAILABILITY STATEMENT The data that support the findings of this study are available from the corresponding author upon reasonable request.

Jan 1, 2024 | jacc.org | Ido Goldenberg |Mehmet Aktaş |Wojciech Zareba |David Huang

References1. "Cardiac resynchronization therapy reduces ventricular arrhythmias in primary but not secondary prophylactic implantable cardioverter defibrillator patients: insight from the Resynchronization in Ambulatory Heart Failure Trial". Circ Arrhythm Electrophysiol . 2017;10:3: e004875. 2. "Cardiac-resynchronization therapy for the prevention of heart-failure events". N Engl J Med . 2009;361:1329-1338. 3. "Cardiac-resynchronization therapy for mild-to-moderate heart failure". N Engl J Med .

Oct 23, 2023 | mdpi.com | Shmuel Tiosano |Ariel Banai |Wesam Mulla |Ido Goldenberg

4. DiscussionOral anticoagulation is recommended as the first-line therapy for preventing ischemic stroke in patients with AF and a CHA2DS2-VASc ≥ 1 in males and ≥2 in females [14]. LAAO initially emerged as an alternative therapeutic strategy for patients unable to tolerate anticoagulation or those who preferred to avoid long-term use. It proved its benefits over warfarin in several randomized controlled trials [21,22,23].

Oct 1, 2023 | jacc.org | Alexander Diamond |Ilan Goldenberg |Arwa Younis |Ido Goldenberg

References1. "Beta-blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials". BMC Cardiovasc Disord . 2013;13:1: 52. https://doi.org/10.1186/1471-2261-13-52. 2. "Beta-blocker treatment in heart failure". Fundam Clin Pharmacol . 2001;15:2: 95-109. 3. "The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial". Lancet . 1999;353:9146: 9-13. 4.